St. Luke’s University Health Network trauma surgeon Stan Stawicki, MD, has been recognized as one of the world’s top-cited scientists for his contributions to clinical trials and research. His work focuses on making new discoveries and improving patient care through innovative treatment methods.
Clinical Trials and Innovative Treatments
Dr. Stawicki is currently the principal investigator in a clinical trial evaluating tissue adhesives as a potential replacement for sutures in wound closure. "It’s a whole new way of looking at wound closure," he stated, highlighting the institution's commitment to cutting-edge research.
Addressing Critical Surgical Challenges
His previous research includes a clinical trial focused on determining the optimal duration of antibiotic treatment following bowel perforation, addressing inconsistencies in treatment approaches. Additionally, Dr. Stawicki has investigated methods to reduce adhesions in complex abdominal surgeries, finding ways to improve outcomes for patients requiring open abdomen management.
Impact on Patient Management and Global Guidelines
Dr. Stawicki was also part of an international consortium that published COVID-19 guidelines, demonstrating his broad impact on patient management. "Research and clinical trials are a big responsibility because what we do directly affects how patients are managed," Dr. Stawicki noted, emphasizing the importance of data integrity and adherence to regulations.
Commitment to Research and Patient Outcomes
Another study he contributed to examined antibiotic use in severe open lower extremity fractures. "Personally," he said, "it’s very satisfying to be involved with clinical trials. You feel like you’re making a difference."
Dr. Stawicki emphasized the collaborative nature of research at St. Luke’s, highlighting the institution's world-class team of clinical trials professionals and investigators. "Thinking local, I look at research as something that helps St. Luke’s make every day medical care better."
